NCT03875820 2026-03-10FRAMEInstitute of Cancer Research, United KingdomPhase 1 Active not recruiting87 enrolled
NCT02546531 2021-07-20Defactinib Combined With Pembrolizumab and Gemcitabine in Patients With Advanced CancerWashington University School of MedicinePhase 1 Completed43 enrolled